Regeneron Pharmaceuticals, Inc. (REGN)
852.29
+28.47
(+3.46%)
USD |
NASDAQ |
Sep 02, 16:00
850.01
-2.28
(-0.27%)
After-Hours: 18:14
Regeneron Pharmaceuticals Net Income (TTM) : 4.329B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.329B |
| March 31, 2026 | 4.423B |
| December 31, 2025 | 4.505B |
| September 30, 2025 | 4.578B |
| June 30, 2025 | 4.459B |
| March 31, 2025 | 4.499B |
| December 31, 2024 | 4.413B |
| September 30, 2024 | 4.654B |
| June 30, 2024 | 4.322B |
| March 31, 2024 | 3.858B |
| December 31, 2023 | 3.954B |
| September 30, 2023 | 3.991B |
| June 30, 2023 | 4.299B |
| March 31, 2023 | 4.183B |
| December 31, 2022 | 4.338B |
| September 30, 2022 | 5.370B |
| June 30, 2022 | 5.687B |
| March 31, 2022 | 7.934B |
| December 31, 2021 | 8.075B |
| September 30, 2021 | 6.996B |
| June 30, 2021 | 6.205B |
| March 31, 2021 | 4.004B |
| December 31, 2020 | 3.513B |
| September 30, 2020 | 3.156B |
| June 30, 2020 | 2.984B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.279B |
| December 31, 2019 | 2.116B |
| September 30, 2019 | 2.144B |
| June 30, 2019 | 2.069B |
| March 31, 2019 | 2.428B |
| December 31, 2018 | 2.444B |
| September 30, 2018 | 1.798B |
| June 30, 2018 | 1.591B |
| March 31, 2018 | 1.428B |
| December 31, 2017 | 1.199B |
| September 30, 2017 | 1.278B |
| June 30, 2017 | 1.155B |
| March 31, 2017 | 963.07M |
| December 31, 2016 | 895.52M |
| September 30, 2016 | 797.40M |
| June 30, 2016 | 743.00M |
| March 31, 2016 | 741.42M |
| December 31, 2015 | 636.06M |
| September 30, 2015 | 591.24M |
| June 30, 2015 | 460.56M |
| March 31, 2015 | 358.65M |
| December 31, 2014 | 348.07M |
| September 30, 2014 | 334.70M |
| June 30, 2014 | 396.29M |
| March 31, 2014 | 390.93M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| AbbVie, Inc. | 6.274B |
| Gilead Sciences, Inc. | -3.24B |
| Amgen, Inc. | 8.743B |
| Biogen, Inc. | 834.60M |